FDA approves lung cancer drug #MPAR

June 3rd 2021 Recently, the FDA approved an Amgen drug, sotorasib, for non-small cell lung cancer (NSCLS) with a specific mutation in a gene known as Kirsten rat sarcoma viral oncogene homolog (KRAS) in patients whose disease has worsened after treatment with chemotherapy or other medicines. This mutation accounts for 13% of NSCLS—the most common … Continue reading FDA approves lung cancer drug #MPAR

Advances from Animal Research: AIDS and Zika Vaccines Update

April 19th, 2021Professor Christopher Petkov Although we have been focusing on updates on Covid-19 vaccines and their reliance on research with nonhuman animals including primates (as an example post see here), two other developments focusing on treatments for AIDS and Zika fever have caught our eye. These fall under the topic #MPAR, Made Possible by … Continue reading Advances from Animal Research: AIDS and Zika Vaccines Update

Sea Lions are a Crucial Model for Understanding how Cancer Develops

April 1st 2021 Most cancers are caused by many complex factors including aspects of the environment, such as toxins and pollutants, and genetic predispositions, such as having the BRCA1 and BRCA2 gene in breast cancer. This complexity makes it challenging to capture all possible factors causing cancer in traditional laboratory models, such as the mouse. … Continue reading Sea Lions are a Crucial Model for Understanding how Cancer Develops